13. May 2022 • Knowledge intensive service
The Mainz-based company BioNTech and the Fraunhofer IZI’s Molecular Drug Biochemistry and Therapy Development department, based in Halle (Saale), will collaborate in the field of biological assays in the future.
The Fraunhofer researchers will contribute their many years of expertise in establishing cellular and molecular biological analysis and model systems to the collaboration. In addition to cell-based assays, they will perform gene expression analyses as well as immunological and protein chemical methods for in vitro characterization.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
Chimeric Antigen Receptor T Cell Therapy (CAR-T): Genetically programmed immune cell binds to and destroys cancer cell / Therapy is now available for the majority of indications
digital-health
Human who looks onto a recording of brainwaves on his tablet computer and moves the model with his fingers
The Smart Infrastructure Hub Leipzig will receive a further 1,9 million euros from the cluster funding of the Saxon Ministry of Economic Affairs.
cell-immune-gene-therapies
Small glas bottle which is normally used to store vaccine
A relatively small metropolis in Germany’s Free State of Saxony – a dynamic hub for the life science industry? What was just a vision 20 years ago has become a reality for the city of Leipzig, which from October 24-26 co-hosted BIO-Europe, Europe’s largest annual biotech partnering event.
services
Woman who looks at something through a microscope while another woman ist watching her
The European Commission has approved the Saxon ERDF/JTF program for the funding period 2021 to 2027.
